Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medios AG (DE:ILM1)
XETRA:ILM1
Holding DE:ILM1?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2024
|% Change Since: -22.81%
|Next Earnings Date:Mar 26, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong financial performance and strategic advancements, despite some challenges in specific segments and increased costs related to acquisitions.Company Guidance
During the Q3 2024 earnings call for Medios AG, the company provided several key financial metrics and guidance highlights. The company achieved a revenue growth of more than 4% to EUR 1.4 billion for the first nine months of 2024, with a significant EBITDA pre increase of over 20% to EUR 55.8 million. The EBITDA pre margin reached the 5% mark for the first time, driven by strong performances in the PST and Ceban segments. Operational cash flow more than doubled to EUR 27.6 million, and the company confirmed its guidance for 2024, anticipating full-year revenues between EUR 1.9 billion and EUR 2.1 billion and an EBITDA pre in the range of EUR 82 million to EUR 91 million. The company also noted inorganic growth due to the acquisition of Ceban, contributing EUR 47.3 million in revenue and EUR 9.8 million in EBITDA pre for the period June through October 2024. Additionally, Medios is focusing on strategic priorities, including expanding operations into other European countries and entering the production of advanced therapies, with a commitment to maintaining high-quality personalized medicines.Record Q3 Performance
The company posted its best quarter ever with significant earnings growth. EBITDA pre margin reached 5% for the first time, driven by PST and Ceban.
Strong Revenue and EBITDA Growth
Revenue grew by more than 4% to EUR 1.4 billion, with EBITDA pre increasing by more than 20% to EUR 55.8 million.
Successful Integration of Ceban
Ceban's integration is progressing smoothly, contributing significantly to the International Business segment.
Operational Cash Flow Surge
Operational cash flow increased by more than 100% to EUR 27.6 million compared to the same period last year.
Positive Future Strategy
The company is focusing on strengthening core business in Germany and expanding into other European countries, with plans to enter advanced therapies production.
---
DE:ILM1 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:ILM1 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | €15.56 | €14.76 | -5.14% |
| Aug 13, 2024 | €17.94 | €17.92 | -0.11% |
| May 07, 2024 | €14.00 | €14.32 | +2.29% |
| Mar 27, 2024 | €16.36 | €15.92 | -2.69% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Medios AG (DE:ILM1) report earnings?
Medios AG (DE:ILM1) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Medios AG (DE:ILM1) earnings time?
Medios AG (DE:ILM1) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Medios AG stock?
The P/E ratio of Medios AG is 22.9.
What is DE:ILM1 EPS forecast?
Currently, no data Available
---